Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
MP0260
print preview
bookmark
share with colleague
General Information
Company
Molecular Partners AG
Description
Designed ankyrin repeat protein (DARPin) that inhibits platelet derived growth factor B (PDGFB; PDF2) and vascular endothelial growth factor A (VEGF-A)
Molecular Target
Platelet derived growth factor B (PDGFB) (PDGF2)
;
Vascular endothelial growth factor A (VEGF-A)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Age-related macular degeneration (AMD)
Partner
Allergan Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy